Osimertinib in EGFR T790M-Positive Lung Cancer

Yue Yin¹, Jun Li¹

Affiliations

Comment

Yue Yin et al. N Engl J Med. 2017.

. 2017 May 18;376(20):1993.

doi: 10.1056/NEJMc1703339.

Yue Yin¹, Jun Li¹

No abstract available

Comment in

Osimertinib in EGFR T790M-Positive Lung Cancer.
Mok TS, Wu YL, Papadimitrakopoulou VA. Mok TS, et al. N Engl J Med. 2017 May 18;376(20):1993-4. doi: 10.1056/NEJMc1703339. N Engl J Med. 2017. PMID: 28514610 No abstract available.

Osimertinib or Platinum-Pemetrexed in EGFR T790M-Positive Lung Cancer.
Mok TS, Wu Y-L, Ahn M-J, Garassino MC, Kim HR, Ramalingam SS, Shepherd FA, He Y, Akamatsu H, Theelen WS, Lee CK, Sebastian M, Templeton A, Mann H, Marotti M, Ghiorghiu S, Papadimitrakopoulou VA; AURA3 Investigators. Mok TS, et al. N Engl J Med. 2017 Feb 16;376(7):629-640. doi: 10.1056/NEJMoa1612674. Epub 2016 Dec 6. N Engl J Med. 2017. PMID: 27959700 Free PMC article. Clinical Trial.